0
Sign In  | Subscribe
1 May 2001, Vol 134, No. 9_Part_1>
Summaries for Patients | 1 May 2001

Avoiding Low Blood Sugar Levels Restores Diabetic Patients' Ability To Recognize the Warning Symptoms of Low Blood Sugar FREE

[+] Article and Author Information

Copyright ©2004 by the American College of Physicians

The summary below is from the full report titled “Avoidance of Hypoglycemia Restores Hypoglycemia Awareness by Increasing β-Adrenergic Sensitivity in Type 1 Diabetes.” It is in the 1 May 2001 issue of Annals of Internal Medicine (volume 134, pages 729-736). The authors are A Fritsche, N Stefan, H Häring, J Gerich, and M Stumvoll.


Ann Intern Med. 2001;134(9_Part_1):S1-. doi:10.7326/0003-4819-134-9 Part 1-200105010-00004
Text Size: A A A

What is the problem and what is known about it so far?

Diabetes is a disease characterized by elevations in blood sugar (glucose). Insulin treatment reduces glucose levels, sometimes below normal levels. Extremely low levels of glucose can cause changes in mental function, seizures, and coma. Diabetic patients can usually sense early warning symptoms of low blood sugar, such as sweating, hunger, tremor, or fast heart rate. These warning signs probably depend on the release of adrenalin-like hormones. Unfortunately, some patients stop developing these warning signs, particularly after many episodes of low blood sugar. These people are more likely to have very low levels of glucose, which sometimes result in serious injury.

Why did the researchers do this particular study?

To see whether strict avoidance of low sugar levels restores warning symptoms in diabetic persons and whether adrenalin-like hormones and sensitivity to these hormones play a part in these warning symptoms.

Who was studied?

The study included 10 men receiving insulin for childhood onset–type diabetes. All had had extremely low blood sugar levels that resulted in seizures, coma, or the need to receive glucose through a vein, as well as frequent low blood sugar levels without warning symptoms.

How was the study done?

The men were instructed to measure blood sugar levels five times daily. On the basis of these measurements, insulin dosages were modified to keep sugar levels above a safe level of 70 mg/dL (milligrams per deciliter). Over 4 months, insulin dosages were decreased by an average of about 25%. At the end of this time, the researchers injected enough insulin through a vein to induce low sugar levels and observed whether the men now had warning symptoms. They also tested the men's sensitivity to an adrenalin-like hormone injected into a vein.

What did the researchers find?

None of the men had extremely low blood sugars or severe symptoms during 4 months of daily insulin treatment. The occurrence of blood glucose levels less than 70 mg/dL decreased from an average of 8 times per week to once per week, and average levels of blood sugar increased. When low sugar levels were produced in the research unit, the men experienced warning symptoms. They also responded more strongly to injections of adrenalin-like hormone after 4 months without low blood sugar levels than they did before.

What were the limitations of the study?

The study was small, included only men, and was conducted under carefully controlled circumstances rather than in “real-life” conditions. Long-term harms of altering glucose control were not studied.

What are the implications of the study?

Diabetic patients who are treated with insulin and who have recurrent episodes of low blood sugar may lose their ability to detect low glucose levels, probably because they lose sensitivity to adrenalin-like hormones. The ability to detect low glucose levels may be restored after even a short period of strict avoidance of low glucose levels.

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Compression-Only CPR: Pushing the Science Forward
Cone
AAM 2010;304:1493-1495.
All you need to read in the other general jounals
BMJ 2010;341:c5893-c1494.

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy This Article

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Register Now for a free account
Advertisement

Related Content

Customize your page view by dragging & repositioning the boxes below.

In the Clinic
Chronic Kidney Disease
Ann Intern Med. 2009;150(3):ITC2-1.
Peripheral Arterial Disease
Ann Intern Med. 2007;146(5):ITC3-1.
Topic Collections
PubMed Articles
Managing diabetic patients with moderate or severe renal impairment using DPP-4 inhibitors: focus on vildagliptin.
Diabetes, metabolic syndrome and obesity : targets and therapy Issue date: 2013
Efficacy and safety of biphasic insulin aspart 30/70 in type 2 diabetes suboptimally controlled on oral antidiabetic therapy in Korea: a multicenter, open-label, single-arm study.
Diabetes & metabolism journal Issue date: 2013 Apr

Annals of Internal Medicine

Other Resources

Copyright © 2013 The American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Buy This Article

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Register Now for a free account
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)